Merkel cell carcinoma and rare/aggressive melanoma and non-melanoma skin cancers

Name: Merkel cell carcinoma and rare/aggressive melanoma and non-melanoma skin cancers
Brand: HealthCert Education
SKU: SHOP-D7MED
Price: 195.00 AUD
Availability: InStock

Explore the complexities of Merkel cell carcinoma and rare, aggressive skin cancers in this comprehensive course designed for medical professionals. Gain advanced knowledge of the clinical presentation, diagnosis, and management of these challenging malignancies, supported by evidence-based insights and real-life case studies. With guidance from leading experts, this course delves into histopathology, dermoscopy, and innovative treatment options for melanoma, non-melanoma skin cancers, and uncommon tumors. Enhance your diagnostic skills and patient outcomes with interactive discussions and practical assessments. Perfect for healthcare providers dedicated to mastering rare and aggressive skin conditions.

$195

FLEXIBLE TIMING

100% ONLINE

accredited COURSE

EXPERT INSTRUCTOR

The Merkel Cell Carcinoma and Rare/Aggressive Melanoma and Non-Melanoma Skin Cancers course is a specialised learning experience tailored for healthcare professionals managing complex cutaneous malignancies. Delivered by prominent experts, the course integrates theory, clinical imagery, and case-based learning to improve diagnostic accuracy and therapeutic strategies.

Unit 1: Merkel Cell Carcinoma and Rare Aggressive Tumors
Led by A/Prof. John Pyne, this unit introduces participants to rare malignancies, emphasising their high morbidity and mortality. Topics include Merkel cell carcinoma, microcystic adnexal carcinoma, sebaceous carcinoma, and nodular melanoma. Participants will explore clinical and histopathological features, focusing on aggressive behaviours and challenges in early detection and management.

Unit 2: Advanced Cases with Dr. Cliff Rosendahl
Building on Unit 1, this section focuses on detailed case studies, including Fibroepithelioma of Pinkus, lymphomas, and poorly differentiated squamous cell carcinomas. Participants will analyse dermoscopic images and learn to identify atypical vascular patterns and structural clues, supported by expert commentary and practical diagnostic strategies.

Unit 3: Rare Tumors by Dr. Luc Thomas
Dr. Luc Thomas presents an array of rare adnexal tumors and sarcomas. This unit emphasises histological nuances and the importance of comprehensive biopsies. Real-world cases illustrate the subtle differences between aggressive malignancies and benign mimics, refining participants’ ability to diagnose with confidence.

Additional Features:
- Interactive case discussions with peer and expert input
- Two online assessments to solidify knowledge: multiple-choice and scenario-based questions
- Access to recommended readings and practical tools to reinforce learning

This course equips medical professionals with advanced expertise to address the diagnostic and therapeutic challenges posed by rare and aggressive skin cancers, ultimately enhancing patient care outcomes.

CPD Hours:

Education hours: 4.0
Reviewing performance hours: 6.0
Measuring outcome hours: 0.0

Accreditations:

Royal Australian College of General Practice (RACGP) #407624

Australian College of Rural and Remote Medicine (ACRRM) #28102

Study Mode:

100% online

Study duration:

10.0 hrs self-paced

Associate Professor John Pyne

This course is presented by Associate Professor John Pyne: MBBS BOptom (Hons 1) MMed Phd FSCCA.

Associate Professor John Pyne was conferred with a Master of Medicine at The University of Queensland, then held a position of Program Director for The University of Queensland Skin Cancer Masters from 2007 until 2013. The thesis for John’s PhD was on the correlations between dermatoscopy and histopathology for BCC and SCC. He is also a past President and Fellow of the Skin Cancer College of Australasia. John has a main interest in the optical imaging of early primary non-lymphoid cutaneous malignancy and correlations with histopathology. He is currently investigating surgical margins in management of these cancers. John has teaching appointments at The Universities of Queensland, New South Wales and Western Sydney.

What your colleagues say

"HealthCert courses have become the standard by which you gauge all others."

- Dr K. Abolarinwa MBBS

"This is the pathway to improve your confidence and evolve into the GP you aspire to be"

- Dr S. Shinwari Trainee

"This is the pathway to improve your confidence and evolve into the GP you aspire to be"

-Dr A. Tucker Trainee